A new arm of the ongoing global clinical trials of the ChAdOx1 nCoV-19 vaccine led by AstraZeneca has launched in the US to assess safety, efficacy and immunogenicity of the vaccine for the prevention of COVID-19. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about […]
With support from Royal Philips, Oxford University Hospitals (OUH) NHS Foundation Trust has become one of the earliest UK adopters of a fully digitised cellular pathology (histopathology) department. OUH is one of the first NHS trusts in the country to achieve the milestone of digitising all surgical histology and referral slides within the cellular pathology department. This […]
Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer. The PathLAKE (Pathology Image Data Lake for Analytics Knowledge and Education) digital pathology consortium, led by University Hospital […]
The UNAIDS estimates that 38 million people currently live with human immunodeficiency virus (HIV) infection. Combination antiretroviral treatment has had great success in saving lives but is also associated with numerous medical and public health challenges. Vaccination remains the best and most cost-effective option for controlling HIV infection across the world. Professor Tomáš Hanke jointly […]
Oxford Brookes University has been awarded funding to develop four innovative projects which aim to help the UK’s recovery from the coronavirus pandemic. The funding is part of a £40m government investment to fast-track new technology while supporting the UK’s next generation of cutting-edge small businesses. More than 8,600 projects applied for funding of up […]
Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19. Volunteers in Brazil have begun receiving a trial vaccine against COVID-19, in Latin America’s first phase 3 COVID-19 clinical trial. The trial officially began on Saturday 20th June and will enrol 5,000 volunteers across the country. Vaccinations will take […]
The UK regulator MHRA announced on 26 June that it would again permit recruitment to the COPCOV COVID-19 prevention clinical trial. The MHRA decision came 5 weeks after it reacted immediately to the now-discredited paper published in The Lancet suggesting harms with hydroxychloroquine, and paused recruitment of UK participants. But The Lancet paper was based […]
A new type of aerosol shield designed by motor racing engineers to improve the treatment of COVID-19 patients and safety of clinical staff has been approved for use at a leading NHS trust. Staff at Oxford University Hospitals (OUH) NHS Foundation Trust say the new ‘Oxford Box’ could mark a significant breakthrough in the treatment of […]
Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week. Dr. Shabir Madhi, Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA) who leads the South African Ox1Cov-19 Vaccine VIDA-Trial The first […]
The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19. Oxford researchers have developed a vaccine in order to begin protecting people against the coronavirus as soon as possible and clinical trials are now underway to establish whether the vaccine […]